ZVRA
Zevra Therapeutics Inc.
11.40$
+3.5%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 8.7% | 141.4% | 31.7% | 9.3% | – | – | 8.3% | 8.3% | – | 2.3% | 0.2% | 3.9% | 4.9% | 6.2% | 3.9% | 8.0% | 5.0% | 95.3% | 80.3% | 62.3% | 11.3% | 6.6% | 47.8% | 6.0% | 4.5% | 6.3% | 3.8% | 5.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 91.3% | -41.4% | 68.3% | 90.7% | 100.0% | 100.0% | 91.7% | 91.7% | 100.0% | 97.7% | 99.8% | 96.1% | 95.1% | 93.8% | 96.1% | 92.0% | 95.0% | 4.7% | 19.7% | 37.7% | 88.7% | 93.4% | 52.2% | 94.0% | 95.5% | 93.7% | 96.2% | 95.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 31.5% | 179.1% | 101.8% | 28.3% | 88.8% | 129.1% | 18.7% | 23.8% | 113.9% | 108.8% | 77.7% | 1,727.5% | 187.4% | 487.8% | 272.5% | 87.8% | 424.8% | 312.8% | 236.5% | 296.2% | 82.3% | 16.0% | 13.3% | 13.2% | 7.7% | 12.1% | 11.3% | 11.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 31.5% | 100.0% | 107.5% | 24.9% | 74.2% | 106.8% | 15.6% | 19.2% | 99.1% | 99.0% | 69.0% | 273.7% | 138.3% | 218.9% | 215.2% | 82.7% | 201.0% | 290.0% | 36.1% | 438.6% | 13.3% | 95.8% | 80.3% | 65.0% | 59.6% | 57.4% | 41.7% | 54.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 63.1% | 279.1% | 249.0% | 53.2% | 163.0% | 235.8% | 34.3% | 43.0% | 213.1% | 207.8% | 146.7% | 2,001.2% | 325.6% | 492.8% | 500.1% | 165.8% | 625.7% | 602.8% | 554.5% | 776.7% | 216.7% | 119.7% | 326.7% | 78.1% | 68.2% | 69.5% | 53.9% | 66.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 28.2% | -320.5% | -180.7% | 37.5% | -63.0% | -135.8% | 57.4% | 48.7% | -113.1% | -110.1% | -46.9% | -1,905.2% | -230.5% | -399.0% | -404.0% | -73.8% | -530.7% | -598.1% | -534.8% | -739.0% | -128.0% | -26.3% | -274.5% | 15.9% | 27.3% | 24.4% | 42.3% | 28.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 13.8% | 135.5% | 87.6% | 25.6% | 90.4% | 68.1% | 2.9% | 0.2% | 0.3% | 0.2% | 0.1% | 2.8% | 4.3% | 7.3% | 5.7% | 2.3% | 12.6% | 21.5% | 47.4% | 62.6% | 18.2% | 9.7% | 7.8% | 7.9% | 5.7% | 4.7% | 0.0% | 4.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 26.7% | -439.3% | -275.4% | 12.4% | -158.1% | -205.2% | -85.0% | 51.8% | -89.5% | -103.4% | -47.1% | -1,904.4% | -231.4% | -390.5% | -419.4% | -31.3% | -352.0% | -487.4% | -446.3% | -899.2% | -169.1% | -9.4% | 297.2% | -3.7% | 37.1% | 123.7% | 32.3% | 50.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0% | -0.6% | 87.6% | 25.6% | -1.8% | 68.1% | 2.4% | -0.3% | 0.3% | 1.3% | -0.1% | -55.0% | -1.1% | -1.5% | -3.2% | -0.9% | 6.1% | -2.0% | 1.6% | – | 127.6% | 5.8% | 8.5% | -1.7% | 1.5% | 19.1% | 10.2% | 8.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 23.7% | -438.7% | -275.4% | 12.4% | -156.3% | -205.2% | -85.0% | 51.8% | -89.5% | -104.7% | -47.0% | -1,849.4% | -230.2% | -389.0% | -416.2% | -30.4% | -358.1% | -485.3% | -447.9% | -899.2% | -296.8% | -15.2% | 288.7% | -2.1% | 35.6% | 104.6% | 22.1% | 42.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 28.9% | -298.4% | -173.7% | 39.1% | -64.2% | -134.3% | -81.6% | 52.5% | -85.9% | -100.7% | -45.3% | -1,887.7% | -213.2% | -376.8% | -411.2% | -28.0% | -464.2% | -420.3% | -363.7% | -792.9% | -137.2% | 8.3% | 311.3% | 5.6% | 43.9% | 120.0% | 33.1% | 53.7% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.